Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2018-07-31 21:38:17
Reporting Period:
Accepted Time:
2018-07-31 21:38:17
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1642380 Oncocyte Corp OCX () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1472122 Andrew Arno 1010 Atlantic Ave,
Suite 102
Alameda CA 94501
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2018-07-26 52,447 $0.00 52,447 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common stock purchase warrants Acquisiton 2018-07-26 52,447 $0.00 52,447 $3.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
52,447 2019-02-01 2024-02-01 No 4 P Direct
  1. The shares of common stock and the common stock purchase warrants reported in this Form were purchased in "units," with each unit consisting of one share of common stock and one common stock purchase warrant. The purchase price per unit was $2.86.